Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer
Condition(s):Metastatic Castration Resistant Prostate Cancer (mCRPC)Last Updated:March 21, 2024Active, not recruiting